Your browser is no longer supported. Please, upgrade your browser.
Settings
HBIO Harvard Bioscience, Inc. daily Stock Chart
HBIO [NASD]
Harvard Bioscience, Inc.
Index- P/E- EPS (ttm)-0.11 Insider Own4.20% Shs Outstand39.18M Perf Week-12.15%
Market Cap135.95M Forward P/E12.71 EPS next Y0.27 Insider Trans-24.93% Shs Float32.67M Perf Month-16.59%
Income-4.10M PEG- EPS next Q0.07 Inst Own76.00% Short Float3.34% Perf Quarter-38.58%
Sales114.40M P/S1.19 EPS this Y137.90% Inst Trans3.66% Short Ratio8.81 Perf Half Y-33.90%
Book/sh2.19 P/B1.58 EPS next Y34.48% ROA-3.10% Target Price8.50 Perf Year9.29%
Cash/sh0.17 P/C20.29 EPS next 5Y10.00% ROE-6.00% 52W Range3.05 - 6.70 Perf YTD5.15%
Dividend- P/FCF- EPS past 5Y-20.60% ROI3.20% 52W High-48.21% Beta1.32
Dividend %- Quick Ratio1.50 Sales past 5Y-1.70% Gross Margin50.40% 52W Low13.77% ATR0.21
Employees413 Current Ratio2.80 Sales Q/Q52.90% Oper. Margin-0.10% RSI (14)34.22 Volatility6.85% 6.08%
OptionableYes Debt/Eq0.75 EPS Q/Q62.60% Profit Margin-4.20% Rel Volume0.25 Prev Close3.54
ShortableYes LT Debt/Eq0.73 EarningsJan 24 AMC Payout- Avg Volume123.96K Price3.47
Recom1.30 SMA20-8.59% SMA50-17.50% SMA200-30.58% Volume31,499 Change-1.98%
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Nov-23-18 07:25AM  Report: Exploring Fundamental Drivers Behind Harvard Bioscience, TTM Technologies, BSQUARE, United Therapeutics, KCAP Financial, and Gladstone Capital New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-21-18 11:04AM  Harvard Bioscience Inc (NASDAQ:HBIO): Time For A Financial Health Check Simply Wall St.
Nov-02-18 02:30PM  Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018 GlobeNewswire
Oct-31-18 12:04AM  Edited Transcript of HBIO earnings conference call or presentation 25-Oct-18 8:30pm GMT Thomson Reuters StreetEvents
Oct-25-18 07:00PM  Harvard Bioscience (HBIO) Meets Q3 Earnings Estimates Zacks
05:55PM  Harvard Bioscience: 3Q Earnings Snapshot Associated Press
04:02PM  Harvard Bioscience Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-23-18 08:35AM  The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares Benzinga
Oct-22-18 04:11PM  Harvard Bioscience Names Kam Unninayar as Chief Financial Officer GlobeNewswire
Oct-18-18 04:30PM  Harvard Bioscience Schedules Third Quarter 2018 Conference Call for October 25 at 4:30 PM ET GlobeNewswire -5.17%
01:50PM  Harvard Bioscience Inc (NASDAQ:HBIO): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
Sep-18-18 07:12AM  Harvard Bioscience Sees Hammer Chart Pattern: Time to Buy? Zacks
Sep-13-18 07:03AM  The Zacks Analyst Blog Highlights: BG, Harvard Bioscience, Vertex Energy, Hallmark and Summer Infant Zacks
Sep-12-18 08:11AM  Small Firms Break 35-Year Record Set in Reagan Era: 5 Picks Zacks
Aug-31-18 02:46PM  Penny Stocks to Buy Using Technical Analysis for September 2018 Investopedia
Aug-22-18 08:48AM  Harvard Bioscience CFO Robert Gagnon resigns MarketWatch -8.06%
Aug-16-18 09:30AM  Is Harvard Bioscience (HBIO) Stock Outpacing Its Computer and Technology Peers This Year? Zacks
Jul-31-18 07:09PM  Edited Transcript of HBIO earnings conference call or presentation 26-Jul-18 8:30pm GMT Thomson Reuters StreetEvents
Jul-27-18 08:44AM  Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter Benzinga +5.66%
Jul-26-18 04:01PM  Harvard Bioscience Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-19-18 09:00AM  Harvard Bioscience Schedules Second Quarter 2018 Conference Call for July 26 at 4:30 PM ET GlobeNewswire
Jun-23-18 10:45AM  Is There Now An Opportunity In Harvard Bioscience Inc (NASDAQ:HBIO)? Simply Wall St.
Jun-20-18 04:01PM  Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants For Measuring Continuous Blood Glucose GlobeNewswire
Jun-13-18 04:01PM  Harvard Bioscience Subsidiary Data Sciences International Launches Inhalation Exposure System GlobeNewswire
May-14-18 05:51PM  Edited Transcript of HBIO earnings conference call or presentation 2-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-02-18 05:51PM  Harvard Bioscience: 1Q Earnings Snapshot Associated Press
04:01PM  Harvard Bioscience Reports First Quarter 2018 Financial Results GlobeNewswire
May-01-18 05:00PM  Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market GlobeNewswire
04:30PM  Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research GlobeNewswire
Apr-25-18 09:41AM  Zacks.com featured highlights include: TheStreet, Joint, Harvard Bioscience and CPI Zacks
06:42AM  Should You Be Content With Harvard Bioscience Incs (NASDAQ:HBIO) Earnings Growth? Simply Wall St.
Apr-24-18 08:15AM  4 Breakout Stocks Offering Phenomenal Returns Zacks
Apr-23-18 04:05PM  Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET GlobeNewswire
Apr-12-18 11:20AM  Can The Uptrend Continue for Harvard Bioscience (HBIO)? Zacks
Mar-22-18 01:20PM  4 Top-Ranked Tech Stocks Under $20 With Room to Run InvestorPlace
09:59AM  4 Top-Ranked Tech Stocks Under $20 With Room to Run Zacks
Mar-05-18 02:01PM  Edited Transcript of HBIO earnings conference call or presentation 1-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-01-18 04:49PM  Harvard Bioscience posts 4Q profit Associated Press
04:01PM  Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results GlobeNewswire
12:00PM  Harvard Bioscience, Inc. to Host Earnings Call ACCESSWIRE
09:15AM  An Intrinsic Value Calculation For Harvard Bioscience Inc (NASDAQ:HBIO) Shows Investors Are Overpaying Simply Wall St.
Feb-22-18 04:45PM  Harvard Bioscience Schedules Fourth Quarter 2017 Conference Call for March 1 at 4:30 PM ET GlobeNewswire
Jan-31-18 06:45PM  Harvard Bioscience Completes Acquisition of Data Sciences International GlobeNewswire
Jan-23-18 05:45PM  Harvard Bioscience snaps up lab equipment firm for $70M American City Business Journals +11.54%
05:30PM  Twin Cities lab animal monitoring company to be sold for $70M American City Business Journals
Jan-22-18 04:01PM  Harvard Bioscience To Acquire Data Sciences International and Sells Denville Scientific GlobeNewswire
Dec-18-17 03:38PM  ETFs with exposure to Harvard Bioscience, Inc. : December 18, 2017 Capital Cube
Dec-07-17 01:58PM  ETFs with exposure to Harvard Bioscience, Inc. : December 7, 2017 Capital Cube
Nov-08-17 06:14PM  ETFs with exposure to Harvard Bioscience, Inc. : November 8, 2017 Capital Cube
Nov-07-17 08:17AM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube -7.52%
Oct-29-17 09:41AM  Edited Transcript of HBIO earnings conference call or presentation 26-Oct-17 8:30pm GMT Thomson Reuters StreetEvents
Oct-26-17 06:03PM  Harvard Bioscience reports 3Q loss Associated Press
04:01PM  Harvard Bioscience Reports Third Quarter 2017 Financial Results GlobeNewswire
09:15AM  Harvard Bioscience, Inc. to Host Earnings Call ACCESSWIRE
Oct-25-17 04:30PM  Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors GlobeNewswire
Oct-20-17 10:14AM  ETFs with exposure to Harvard Bioscience, Inc. : October 20, 2017 Capital Cube
Oct-18-17 04:30PM  Harvard Bioscience Schedules Third Quarter 2017 Conference Call for October 26 at 4:30 PM ET GlobeNewswire
Oct-09-17 11:36AM  ETFs with exposure to Harvard Bioscience, Inc. : October 9, 2017 Capital Cube
Oct-06-17 09:14AM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Aug-11-17 09:21PM  Edited Transcript of HBIO earnings conference call or presentation 27-Jul-17 8:30pm GMT Thomson Reuters StreetEvents
Jul-27-17 11:36PM  Harvard Bioscience reports 2Q loss Associated Press
04:02PM  Harvard Bioscience Reports Second Quarter 2017 Financial Results GlobeNewswire
Jul-18-17 05:15PM  Harvard Bioscience Schedules Second Quarter 2017 Conference Call for July 27 at 4:30 PM ET GlobeNewswire
Jul-05-17 12:46PM  ETFs with exposure to Harvard Bioscience, Inc. : July 5, 2017 Capital Cube
Jun-08-17 01:38PM  ETFs with exposure to Harvard Bioscience, Inc. : June 8, 2017 Capital Cube +6.00%
Jun-07-17 04:05PM  Harvard Bioscience Elects James Green as Chairman of Board of Directors GlobeNewswire -5.66%
May-11-17 04:47PM  ETFs with exposure to Harvard Bioscience, Inc. : May 11, 2017 Capital Cube
May-10-17 11:12AM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube +8.16%
May-02-17 07:26PM  Edited Transcript of HBIO earnings conference call or presentation 27-Apr-17 8:30pm GMT Thomson Reuters StreetEvents
Apr-27-17 05:32PM  Harvard Bioscience reports 1Q loss Associated Press
04:01PM  Harvard Bioscience Reports First Quarter 2017 Financial Results GlobeNewswire
11:45AM  Investor Network: Harvard Bioscience, Inc. to Host Earnings Call Accesswire
Apr-19-17 04:05PM  Harvard Bioscience Schedules First Quarter 2017 Conference Call for April 27 at 4:30 PM ET GlobeNewswire
Apr-07-17 04:44PM  ETFs with exposure to Harvard Bioscience, Inc. : April 7, 2017 Capital Cube
Mar-23-17 01:04PM  HARVARD BIOSCIENCE INC Financials
Mar-21-17 11:34AM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube
11:34AM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
09:56AM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017
Mar-17-17 06:04AM  HARVARD BIOSCIENCE INC Files SEC form 10-K, Annual Report -5.36%
Mar-10-17 02:55AM  Edited Transcript of HBIO earnings conference call or presentation 9-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
Mar-09-17 05:14PM  Harvard Bioscience reports 4Q loss Associated Press
04:30PM  Harvard Bioscience Inc Earnings Call scheduled for 4:30 pm ET today
04:06PM  HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:01PM  Harvard Bioscience Reports Fourth Quarter and Year-End 2016 Results and 2017 Financial Guidance GlobeNewswire
07:07AM  Q4 2016 Harvard Bioscience Inc Earnings Release - After Market Close
Feb-23-17 04:30PM  Harvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET GlobeNewswire
Jan-12-17 02:05PM  ETFs with exposure to Harvard Bioscience, Inc. : January 12, 2017 Capital Cube
02:05PM  ETFs with exposure to Harvard Bioscience, Inc. : January 12, 2017
Dec-19-16 11:00AM  Harvard Bioscience an 'Asymmetrical Long Shot' TheStreet.com
11:00AM  Harvard Bioscience an 'Asymmetrical Long Shot'
Dec-16-16 11:42AM  ETFs with exposure to Harvard Bioscience, Inc. : December 16, 2016 Capital Cube
11:42AM  ETFs with exposure to Harvard Bioscience, Inc. : December 16, 2016
08:16AM  Harvard Bioscience, Inc. (HBIO): Are Hedge Funds Right About This Stock? Insider Monkey
08:16AM  Harvard Bioscience, Inc. (HBIO): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-17-16 12:51PM  Coverage initiated on Harvard Biosci by Singular Research
Nov-03-16 04:11PM  HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report
Nov-02-16 01:52PM  ETFs with exposure to Harvard Bioscience, Inc. : November 2, 2016
Oct-31-16 12:25PM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016 Capital Cube
12:25PM  Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
Oct-28-16 07:19PM  Edited Transcript of HBIO earnings conference call or presentation 27-Oct-16 8:30pm GMT
Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company offers physiology, cell, and molecular instruments, such as traditional syringe pump and peristaltic pump products, as well as a range of instruments and accessories for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, and Hugo Sachs brands; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation instruments that are marketed under the Biochrom, Libra, WPA, BioDrop, Hoefer, Scie-plas, and BTX brand names. It also designs, develops, and manufactures precision electrophysiology equipment specializing in patch clamp amplifiers, and manual and automated patch clamp systems under the HEKA brand; manufactures tools for electrophysiology and cell biology research consisting of cell chambers, perfusion controllers, temperature controllers, microincubation systems, and bio-sensing systems under the Warner Instruments brand; and designs and develops in vivo neural interface systems under the TBSI brand for neuroscience research, primarily in the fields of electrophysiology, psychology, neurology, and pharmacology. In addition, the company is involved in the development and manufacture of precision scientific measuring instrumentation and equipment under the Multi-Channel Systems brand; and physiologic monitoring focused on delivering preclinical products, systems, services, and solutions. Harvard Bioscience, Inc. markets its products in approximately 100 countries through sales organization, Websites, catalogs, and distributors to research scientists at universities, hospitals, government laboratories, and pharmaceutical and biotechnology companies. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green James WDirectorAug 29Buy5.742,50014,350154,187Aug 30 04:07 PM
Gagnon Robert E.Chief Financial OfficerAug 29Sale5.778,88951,290321,169Aug 30 04:04 PM
Sun YongVP - Commercial OperationsAug 14Option Exercise4.3150,000215,500299,732Aug 15 04:23 PM
Duchemin JeffreyChief Executive OfficerAug 09Option Exercise4.3144,500191,795835,242Aug 09 05:00 PM
Duchemin JeffreyChief Executive OfficerAug 09Sale6.4144,500285,245790,742Aug 09 05:00 PM
Duchemin JeffreyChief Executive OfficerAug 08Option Exercise4.315,50023,705796,242Aug 09 05:00 PM
Duchemin JeffreyChief Executive OfficerAug 08Sale6.355,50034,925790,742Aug 09 05:00 PM
Gagnon Robert E.Chief Financial OfficerAug 07Option Exercise4.8087,500420,200449,301Aug 09 04:20 PM
Duchemin JeffreyChief Executive OfficerAug 07Option Exercise4.31100,000431,000890,742Aug 09 05:00 PM
Duchemin JeffreyChief Executive OfficerAug 07Sale6.07100,000607,000790,742Aug 09 05:00 PM
Gagnon Robert E.Chief Financial OfficerAug 07Sale6.08100,015608,091349,286Aug 09 04:20 PM
Sun YongVP - Commercial OperationsAug 01Option Exercise4.3150,000215,500299,858Aug 02 06:57 PM
Gagnon Robert E.Chief Financial OfficerJul 27Option Exercise4.2350,000211,700424,315Jul 31 04:08 PM
Gagnon Robert E.Chief Financial OfficerJul 27Sale5.5462,514346,328361,801Jul 31 04:08 PM
Gagnon Robert E.Chief Financial OfficerJul 24Sale5.255,57029,243374,315Jul 26 07:13 PM
Gagnon Robert E.Chief Financial OfficerJul 23Sale5.251,4657,691379,885Jul 23 04:54 PM
Gagnon Robert E.Chief Financial OfficerJul 19Sale5.251,1005,775381,350Jul 23 04:54 PM
Gagnon Robert E.Chief Financial OfficerJul 13Sale5.251,0625,576382,450Jul 16 05:10 PM
Gagnon Robert E.Chief Financial OfficerJul 12Option Exercise4.125,82824,011392,657Jul 16 05:10 PM
Gagnon Robert E.Chief Financial OfficerJul 12Sale5.259,14548,011383,512Jul 16 05:10 PM
Gagnon Robert E.Chief Financial OfficerJul 11Option Exercise4.22116,272490,840528,129Jul 11 09:45 PM
Gagnon Robert E.Chief Financial OfficerJul 11Sale5.23141,300738,999386,829Jul 11 09:45 PM
Duchemin JeffreyChief Executive OfficerJul 11Sale5.2214,20574,150790,742Jul 11 08:12 PM
Gagnon Robert E.Chief Financial OfficerJul 10Option Exercise4.3113,70059,047425,557Jul 11 09:45 PM
Gagnon Robert E.Chief Financial OfficerJul 10Sale5.3813,70073,706411,857Jul 11 09:45 PM
Duchemin JeffreyChief Executive OfficerJul 10Sale5.3811,60062,408804,947Jul 11 08:12 PM
Gagnon Robert E.Chief Financial OfficerJul 09Option Exercise4.3114,20061,202426,057Jul 11 09:45 PM
Gagnon Robert E.Chief Financial OfficerJul 09Sale5.4114,20076,822411,857Jul 11 09:45 PM
Duchemin JeffreyChief Executive OfficerJul 09Sale5.4114,19576,795816,547Jul 11 08:12 PM
UVEGES GEORGEDirectorMar 14Sale4.5822,250101,905142,685Mar 15 09:13 PM
UVEGES GEORGEDirectorMar 12Option Exercise3.416,58622,458169,614Mar 15 09:13 PM
Duchemin JeffreyChief Executive OfficerMar 09Sale4.607,80035,880641,854Mar 12 05:25 PM
Duchemin JeffreyChief Executive OfficerMar 08Sale4.5279,222358,083649,654Mar 12 05:25 PM
UVEGES GEORGEDirectorMar 07Sale4.6135,054161,599163,028Mar 12 05:26 PM
Gagnon Robert E.Chief Financial OfficerMar 07Sale4.6297,087448,542357,938Mar 12 05:23 PM